- call +1-201-465-4211
- email sales@mrinsights.biz
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
Scope of the Report:
This report focuses on the HIV Diagnosis & Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
The worldwide market for HIV Diagnosis & Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global HIV Diagnosis & Treatment market.
Chapter 1, to describe HIV Diagnosis & Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of HIV Diagnosis & Treatment, with sales, revenue, and price of HIV Diagnosis & Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of HIV Diagnosis & Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, HIV Diagnosis & Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe HIV Diagnosis & Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 HIV Diagnosis & Treatment Introduction
1.2 Market Analysis by Type
1.2.1 ELISA Test
1.2.2 Saliva Tests
1.2.3 Viral Load Test
1.2.4 Western Blot
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 HIV Diagnosis & Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 HIV Diagnosis & Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 HIV Diagnosis & Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cipla
2.4.1 Business Overview
2.4.2 HIV Diagnosis & Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cipla HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche
2.5.1 Business Overview
2.5.2 HIV Diagnosis & Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Gilead
2.6.1 Business Overview
2.6.2 HIV Diagnosis & Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Gilead HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 HIV Diagnosis & Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 HIV Diagnosis & Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson HIV Diagnosis & Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global HIV Diagnosis & Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global HIV Diagnosis & Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global HIV Diagnosis & Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 HIV Diagnosis & Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 HIV Diagnosis & Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global HIV Diagnosis & Treatment Market Analysis by Regions
4.1 Global HIV Diagnosis & Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global HIV Diagnosis & Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global HIV Diagnosis & Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
4.3 Europe HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
4.5 South America HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
5 North America HIV Diagnosis & Treatment by Countries
5.1 North America HIV Diagnosis & Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America HIV Diagnosis & Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America HIV Diagnosis & Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
5.3 Canada HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
6 Europe HIV Diagnosis & Treatment by Countries
6.1 Europe HIV Diagnosis & Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe HIV Diagnosis & Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe HIV Diagnosis & Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
6.3 UK HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
6.4 France HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
6.5 Russia HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
6.6 Italy HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific HIV Diagnosis & Treatment by Countries
7.1 Asia-Pacific HIV Diagnosis & Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific HIV Diagnosis & Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific HIV Diagnosis & Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
7.3 Japan HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
7.4 Korea HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
7.5 India HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
8 South America HIV Diagnosis & Treatment by Countries
8.1 South America HIV Diagnosis & Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America HIV Diagnosis & Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America HIV Diagnosis & Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa HIV Diagnosis & Treatment by Countries
9.1 Middle East and Africa HIV Diagnosis & Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa HIV Diagnosis & Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa HIV Diagnosis & Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
9.3 UAE HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa HIV Diagnosis & Treatment Sales and Growth Rate (2013-2018)
10 Global HIV Diagnosis & Treatment Market Segment by Type
10.1 Global HIV Diagnosis & Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global HIV Diagnosis & Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global HIV Diagnosis & Treatment Revenue and Market Share by Type (2013-2018)
10.2 ELISA Test Sales Growth and Price
10.2.1 Global ELISA Test Sales Growth (2013-2018)
10.2.2 Global ELISA Test Price (2013-2018)
10.3 Saliva Tests Sales Growth and Price
10.3.1 Global Saliva Tests Sales Growth (2013-2018)
10.3.2 Global Saliva Tests Price (2013-2018)
10.4 Viral Load Test Sales Growth and Price
10.4.1 Global Viral Load Test Sales Growth (2013-2018)
10.4.2 Global Viral Load Test Price (2013-2018)
10.5 Western Blot Sales Growth and Price
10.5.1 Global Western Blot Sales Growth (2013-2018)
10.5.2 Global Western Blot Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global HIV Diagnosis & Treatment Market Segment by Application
11.1 Global HIV Diagnosis & Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.1 Global HIV Diagnosis & Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 HIV Diagnosis & Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.2.2 Europe HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.2.4 South America HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa HIV Diagnosis & Treatment Market Forecast (2018-2023)
12.3 HIV Diagnosis & Treatment Market Forecast by Type (2018-2023)
12.3.1 Global HIV Diagnosis & Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global HIV Diagnosis & Treatment Market Share Forecast by Type (2018-2023)
12.4 HIV Diagnosis & Treatment Market Forecast by Application (2018-2023)
12.4.1 Global HIV Diagnosis & Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global HIV Diagnosis & Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure HIV Diagnosis & Treatment Picture
Table Product Specifications of HIV Diagnosis & Treatment
Figure Global Sales Market Share of HIV Diagnosis & Treatment by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
